Disease burden and quality of life of patients with chronic urticaria in Spain. Prevalence of chronic urticaria refractory to standard therapy in routine clinical practice. UCREX study.
Researchers
-
Albert González Martin
Dermatologist
-
Anna Ravella Matthew
Dermatologist
PhD -
David Vidal Sarro
Dermatologist
PhD -
Gisela Hebe Petiti
Dermatologist
-
Joan Antoni Smandia Domínguez
Dermatologist
PhD -
Laura Peramiquel Fonollosa
Dermatologist
-
Loida Galvany Rosell
Dermatologist
-
Mª Rosa Olivella Garcés
Dermatologist
-
Maria López Nuñez
Dermatologist
-
Maria Villar Buil
Dermatologist
-
Nuria Lamas Domenech
Dermatologist
Contact the group
Form
Projects
-
- Year 2016
- Hospital de Sant Joan Despí Moisès Broggi/Centro Integral Atención Hospital Dos de Maig
Registry of the Catalan and Balearic Urticaria Network (XUrCB).
-
DISTRICT ATTORNEY:
Catalan and Balearic Urticaria Network (XUrCB)
-
TYPE E:
EPA
-
- Year 2016
- Comprehensive Care Center Dos de Maig Hospital/Hospital de Sant Joan Despí Moisès Broggi
"Network of Melanoma Centers" Data shearing platform.
-
DISTRICT ATTORNEY:
Dr. Susana Puigde Melanoma Unit of Hospital Clínic de Barcelona
-
TYPE E:
PINE TREE
-
- Year 2016
- Sant Joan Despí Moisès Broggi Hospital
Multicenter, randomized, double-blind, placebo-controlled, 52-week study to demonstrate the efficacy, safety, and tolerability of secukinumab subcutaneous injections with 2 mL (300 mg) prefilled syringes in adult patients with moderate to severe plaque psoriasis serious
-
DISTRICT ATTORNEY:
Novartis Farmacéutica, SA
-
TYPE E:
RD2015
-
- Year 2016
- Sant Joan Despí Moisès Broggi Hospital/Dos de Maig Hospital Integral Care Center
Registration of the Catalan and Balearic Urticaria Network (XUrCB).
-
DISTRICT ATTORNEY:
Catalan and Balearic Urticaria Network (XUrCB)
-
TYPE E:
EPA
-
Dermatologist
Researcher
- Year 2015
- Comprehensive Care Center Dos de Maig Hospital
Analysis of gene expansion in lesional and non-lesional biopsy of a psoriatic patient in cultivation.
-
DISTRICT ATTORNEY:
Dr. Luis F. Santamaria
-
TYPE E:
PI
-
Dermatologist
Researcher
- Year 2015
- Comprehensive Care Center Dos de Maig Hospital
Study of inhibitors of the II-23/TH17 axis in cultures of Th17 lymphocytes in cultures of T lymphocytes and psoriatic epidemic cells in vitro.
-
DISTRICT ATTORNEY:
Dr. Luis F. Santamaria- UB
-
TYPE E:
PI
-
Dermatologist
Researcher
- Year 2015
- Sant Joan Despí Moisès Broggi Hospital
ECO-HS Study: Transversal and multicenter study to evaluate ultrasound as a characterization tool in the diagnosis of patients with hidradenitis suppurativa.
-
DISTRICT ATTORNEY:
Abbvie Spain, SLU
-
TYPE E:
PI
-
Dermatologist
Researcher
- Year 2015
- Sant Joan Despí Moisès Broggi Hospital
Multicentric observational study to establish the prevalence, clinical profile and therapeutic management of patients with Hidradenitis suppurativa in dermatology hospital services and health centers in Spain.
-
DISTRICT ATTORNEY:
AbbVie Spain, SLU
-
TYPE E:
EPA
-
Dermatologist
Researcher
- Year 2015
- Sant Joan Despí Moisès Broggi Hospital
OPTiMISE (Optimization of Maintenance Treatment with Secukinumab 300 mg) [Optimization of long-term maintenance treatment of white skin in patients with moderate to severe chronic plaque psoriasis: Randomized, multicenter, open-label study with blinded evaluation, comparative 52-week follow-up to evaluate the efficacy, safety and tolerability of secukinumab 300 mg sc
-
DISTRICT ATTORNEY:
Novartis
-
TYPE E:
RD2004
-
Dermatologist
Researcher
- Year 2015
- Sant Joan Despí Moisès Broggi Hospital
Multicentric observational study to establish the prevalence, clinical profile and therapeutic management of patients with Hidradenitis suppurativa in dermatology hospital services and health centers in Spain.
-
DISTRICT ATTORNEY:
AbbVie Spain, SLU
-
TYPE E:
EPA
Lines of action
- Immune mediated skin diseases
- Skin cancer
- neurofibromatosis
- Ultrasonography
